Skip to main content

Biomax Develops Management Infrastructure for Respiratory Disease Consortium

Premium

Biomax Informatics said this week that its knowledge management infrastructure is being used to manage information for a European-funded project focused on studying airway diseases.

According to Biomax, the Airway Disease Predicting Outcomes through Patient Specific Computational Modeling, or AirPROM, consortium will use its BioXM system to semantically integrate clinical, physiological, genetic, and experimental data as well as to share information within the consortium and beyond.

The consortium intends to develop computational models that can predict airway disease progression and responses to therapy and elucidate the relationships between clinical phenotype, genotype, airway structure, and physiology.

These models are expected to provide a tool to help healthcare providers make better treatment decisions for patients.

BioXM is also being used by scientists involved in the Synergy-COPD project, which aims to study the underlying mechanisms of chronic obstructive pulmonary disease phenotypes associated with poor prognosis (BI 6/22/2012).

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.